Company: SUNE
Filing Date: 2025-08-18
Form Type: 424B5
Source: 0001213900-25-078001
Chunk: 37

Company: SUNation Energy, Inc.
Filing Date: 2025-08-18
Form: 424B5
Chunk 37
---
 April 11, 2025, we received a new non-compliance notice notifying the Company that, for the 30 consecutive business day period
immediately preceding deficiency letter, the Company’s common stock had not maintained a minimum closing bid price of $1.00 per
share (the “Minimum Bid Price Requirement”) and, as a result, does not comply with Listing Rule 5550(a)(2) (the “Rule”).
Normally, a company would be afforded a 180-calendar day period (“Cure Period”) to demonstrate compliance with such deficiency;
however, pursuant to Listing Rule 5810(c)(3)(A)(iv), the Company is not eligible for a customary Cure Period specified in Rule 5810(c)(3)(A)
due to the fact that the Company has effected a reverse stock split over the prior one-year period or has effected one or more reverse
stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one.. Instead, the Company is offered an
opportunity to appeal any deficiency related to a delisting determination to Nasdaq within seven days from receipt of the non-compliance
notice. Accordingly, unless the Company timely requests a hearing before a Hearings Panel, the Company’s securities would be subject
to suspension/delisting. The Company intends to timely request a hearing before the Hearing Panel. While the hearing request will automatically
stay any suspension or delisting action pending the hearing and the expiration of any additional extension period if granted by the Panel
following the hearing, there can be no assurance that the Panel will grant the Company an additional extension period or that the Company
will ultimately regain compliance with all applicable requirements for continued listing on The Nasdaq Capital Market. Additionally, to
this end, the stockholders of the Company had approved a share consolidation on April 3, 2025 that has been effectuated within the discretion
of the board of directors of the Company and, if such action ultimately resolves the above noted Nasdaq listing compliance deficiency
prior to such hearing date, then we may be mooted out of the hearing; however, there can be no assurance that this action by us will result
in regaining compliance with the deficiency for a sufficiently long period, or that the we may be delisted despite taking all such remedial
actions to avoid such a negative result.

Our substantial level of indebtedness and our current liquidity constraints could adversely affect our financial condition and our ability to service our indebtedness, which could negatively impact your